Edition:
United Kingdom

Ra Pharmaceuticals Inc (RARX.OQ)

RARX.OQ on NASDAQ Stock Exchange Global Market

15.78USD
21 Sep 2018
Change (% chg)

$0.20 (+1.28%)
Prev Close
$15.58
Open
$15.58
Day's High
$16.13
Day's Low
$15.41
Volume
84,816
Avg. Vol
82,464
52-wk High
$17.90
52-wk Low
$4.93

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.49 December 22 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 5 5 5 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 1.83 1.83 1.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Quarter Ending Dec-18 3 0.83 2.50 0.00 --
Year Ending Dec-18 3 2.67 5.50 0.00 29.37
Year Ending Dec-19 3 2.33 4.00 0.00 28.10
Earnings (per share)
Quarter Ending Sep-18 4 -0.49 -0.37 -0.54 --
Quarter Ending Dec-18 4 -0.54 -0.47 -0.59 --
Year Ending Dec-18 5 -2.13 -2.04 -2.22 -1.90
Year Ending Dec-19 5 -2.17 -1.95 -2.32 -2.95

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 0.62 0.00 0.62 100.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.83 0.00 0.83 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.00 0.00 1.83 2.75 --
Quarter Ending Dec-18 0.83 0.83 0.83 0.00 --
Year Ending Dec-18 2.67 2.67 2.67 3.40 29.37
Year Ending Dec-19 2.33 2.33 2.33 3.35 28.10

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 1
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings